Orion Biotech Opportunities Corp. Units
ORIAU
ORIAU was delisted on the 25th of April, 2023.
6 hedge funds and large institutions have $15.7M invested in Orion Biotech Opportunities Corp. Units in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 6 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25% less capital invested
Capital invested by funds: $21M → $15.7M (-$5.22M)
45% less funds holding
Funds holding: 11 → 6 (-5)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$3.68M |
| 2 |
WC
Wealthspring Capital
West Harrison,
New York
|
-$972K |
| 3 |
Millennium Management
New York
|
-$323K |
| 4 |
SMA
Sage Mountain Advisors
Atlanta,
Georgia
|
-$149K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$101K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JP
1
JNE Partners
London,
United Kingdom
| $14.7M | – | – | – |
|
|
SIA
2
Schechter Investment Advisors
Birmingham,
Michigan
| $916K | – | – | – |
|
|
GAM
3
Gritstone Asset Management
Bethesda,
Maryland
| $160K | +$162K | +16,338 | New |
|
|
6CM
4
683 Capital Management
New York
| $9.77K | – | – | – |
|
|
CS
5
Clear Street
New York
| $3K | -$15.9K | -1,600 | -84% |
|
6
UBS Group
Zurich,
Switzerland
| $1.24K | – | – | – |
|
|
7
Jane Street
New York
| – | -$3.68M | -373,804 | Closed |
|
|
WC
8
Wealthspring Capital
West Harrison,
New York
| – | -$972K | -98,690 | Closed |
|
|
9
Millennium Management
New York
| – | -$323K | -32,826 | Closed |
|
|
SMA
10
Sage Mountain Advisors
Atlanta,
Georgia
| – | -$149K | -15,170 | Closed |
|
|
11
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$101K | -10,288 | Closed |
|
|
WAM
12
Wolverine Asset Management
Chicago,
Illinois
| – | -$9K | -1,000 | Closed |
|
ORIAU Hedge Fund Activity: Q4 2022 in Review
6 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Units (ORIAU) for Q4 2022, worth a combined $15.7M — down 25% from $21M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ORIAU and 1 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Jane Street, exiting entirely with an estimated $3.68M sold.
- 6 institutional investors held Orion Biotech Opportunities Corp. Units (ORIAU) as of Q4 2022, down from 11 in Q3 2022.
- Funds reported $15.7M of Orion Biotech Opportunities Corp. Units stock for Q4 2022, down 25% quarter-over-quarter.
- 1 fund opened new Orion Biotech Opportunities Corp. Units positions in Q4 2022 and 6 closed out, a net change of -5 holders.
- The largest Orion Biotech Opportunities Corp. Units seller in Q4 2022 was Jane Street, an estimated $3.68M sold.
Based on aggregated 13F filings for Q4 2022.